ZA934971B - Novel phospholipid derivatives - Google Patents

Novel phospholipid derivatives

Info

Publication number
ZA934971B
ZA934971B ZA934971A ZA934971A ZA934971B ZA 934971 B ZA934971 B ZA 934971B ZA 934971 A ZA934971 A ZA 934971A ZA 934971 A ZA934971 A ZA 934971A ZA 934971 B ZA934971 B ZA 934971B
Authority
ZA
South Africa
Prior art keywords
phospholipid derivatives
novel phospholipid
novel
derivatives
medicaments
Prior art date
Application number
ZA934971A
Other languages
English (en)
Inventor
Gerhard Noessner
Juergen Engel
Jurij Stekar
Bernhard Kutscher
Wolfgang Schumacher
Peter Hilgard
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of ZA934971B publication Critical patent/ZA934971B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/10Phosphatides, e.g. lecithin
    • C07F9/106Adducts, complexes, salts of phosphatides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/5532Seven-(or more) membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/59Hydrogenated pyridine rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Saccharide Compounds (AREA)
ZA934971A 1992-07-11 1993-07-09 Novel phospholipid derivatives ZA934971B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4222910A DE4222910A1 (de) 1992-07-11 1992-07-11 Neue Phospholipidderivate

Publications (1)

Publication Number Publication Date
ZA934971B true ZA934971B (en) 1994-02-01

Family

ID=6463031

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA934971A ZA934971B (en) 1992-07-11 1993-07-09 Novel phospholipid derivatives

Country Status (31)

Country Link
EP (1) EP0579939B1 (lv)
JP (1) JP3311431B2 (lv)
KR (1) KR100297180B1 (lv)
CN (1) CN1039012C (lv)
AT (1) ATE176477T1 (lv)
AU (1) AU664101B2 (lv)
BR (1) BR9302809A (lv)
CA (2) CA2100228C (lv)
CZ (1) CZ290863B6 (lv)
DE (2) DE4222910A1 (lv)
DK (1) DK0579939T3 (lv)
EE (1) EE03140B1 (lv)
ES (1) ES2129053T3 (lv)
FI (1) FI111262B (lv)
GR (1) GR3029602T3 (lv)
HR (1) HRP931046B1 (lv)
HU (1) HU218783B (lv)
IL (1) IL106289A (lv)
LT (1) LT3113B (lv)
LV (1) LV10870B (lv)
MX (1) MX9304133A (lv)
NO (1) NO306468B1 (lv)
PL (3) PL177811B1 (lv)
RU (1) RU2108336C1 (lv)
SG (1) SG46249A1 (lv)
SI (1) SI9300365B (lv)
SK (1) SK283827B6 (lv)
TW (1) TW304956B (lv)
UA (1) UA40567C2 (lv)
YU (1) YU49079B (lv)
ZA (1) ZA934971B (lv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007008810A (es) 2005-01-21 2007-11-21 Astex Therapeutics Ltd Compuestos farmaceuticos.
AR058397A1 (es) * 2005-12-19 2008-01-30 Zentaris Gmbh Derivados de alquilfosfolipidos con citotoxicidad reducida y usos de los mismos
EP1800684A1 (en) * 2005-12-20 2007-06-27 Zentaris GmbH Novel alkyl phospholipid derivatives and uses thereof
EP1869981A1 (de) * 2006-06-21 2007-12-26 Staatliches Weinbauinstitut Freiburg Alkylphospholipide und Lyso-Phospholipide zur Bekämpfung von Pflanzenpathogenen
EP2073807A1 (en) 2006-10-12 2009-07-01 Astex Therapeutics Limited Pharmaceutical combinations
WO2008044041A1 (en) 2006-10-12 2008-04-17 Astex Therapeutics Limited Pharmaceutical combinations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444766A (en) * 1980-10-21 1984-04-24 Boehringer Mannheim Gmbh Sulfur-containing phospholipid compounds and therapeutic compositions
JPS5984824A (ja) * 1982-11-08 1984-05-16 Takeda Chem Ind Ltd 抗腫瘍剤
DE3530767A1 (de) * 1985-08-28 1987-03-12 Max Planck Gesellschaft Mittel gegen multiple sklerose
IE59777B1 (en) * 1985-12-04 1994-04-06 Max Planck Gesellschaft Medicaments
DE3765502D1 (de) * 1986-07-14 1990-11-15 Nippon Chemiphar Co Glycerolderivat und antihypertensives mittel.
CN1017435B (zh) * 1987-03-24 1992-07-15 日本化学医药株式会社 新的甘油衍生物的制备方法
DE3906952A1 (de) * 1989-03-04 1990-09-06 Boehringer Mannheim Gmbh (3-(c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)6(pfeil abwaerts)-c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)8(pfeil abwaerts))alkansulfinyl- und sulfonyl-2-methoxymethyl-propyl)-(2-trimethylammonio-ethyl) phosphate, verfahren zu deren herstellung diese verbindungen enthaltende arzneimittel
DE3942933A1 (de) * 1989-12-23 1991-06-27 Boehringer Mannheim Gmbh Verwendung von alkylphospholipiden als antivirale arzneimittel und neue phospholipid-derivate
DE4114586A1 (de) * 1991-05-04 1992-11-05 Boehringer Mannheim Gmbh Arzneimittel enthaltend azacyclodiphosphonsaeurederivate, neue azacyclodiphosphonsaeurederivate sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
CA2100228C (en) 2006-01-24
KR940002265A (ko) 1994-02-17
ATE176477T1 (de) 1999-02-15
HRP931046B1 (en) 2000-06-30
DE4222910A1 (de) 1994-01-13
KR100297180B1 (ko) 2001-11-30
PL177811B1 (pl) 2000-01-31
EP0579939B1 (de) 1999-02-03
SK67093A3 (en) 1995-03-08
FI933165A (fi) 1994-01-12
CZ290863B6 (cs) 2002-11-13
SI9300365A (en) 1994-03-31
CN1084175A (zh) 1994-03-23
NO932502D0 (no) 1993-07-08
FI933165A0 (fi) 1993-07-09
YU49079B (sh) 2003-08-29
IL106289A (en) 2000-06-01
NO306468B1 (no) 1999-11-08
FI111262B (fi) 2003-06-30
LT3113B (en) 1994-12-27
SG46249A1 (en) 1998-02-20
ES2129053T3 (es) 1999-06-01
HUT64548A (en) 1994-01-28
SK283827B6 (sk) 2004-02-03
CZ124993A3 (en) 1995-03-15
CA2100228A1 (en) 1994-01-12
RU2108336C1 (ru) 1998-04-10
PL175607B1 (pl) 1999-01-29
JPH0733791A (ja) 1995-02-03
HRP931046A2 (en) 1997-04-30
AU664101B2 (en) 1995-11-02
HU9301992D0 (en) 1993-09-28
LV10870A (lv) 1995-10-20
NO932502L (no) 1994-01-12
YU47393A (sh) 1997-08-22
EE03140B1 (et) 1998-12-15
CA2511753A1 (en) 1994-01-12
PL173388B1 (pl) 1998-02-27
EP0579939A1 (de) 1994-01-26
DK0579939T3 (da) 1999-09-20
LTIP620A (en) 1994-07-15
PL299624A1 (en) 1994-02-21
SI9300365B (sl) 2002-02-28
LV10870B (en) 1996-06-20
AU4186493A (en) 1994-01-13
IL106289A0 (en) 1994-04-12
CA2511753C (en) 2007-09-25
HU218783B (hu) 2000-12-28
DE59309355D1 (de) 1999-03-18
TW304956B (lv) 1997-05-11
MX9304133A (es) 1994-04-29
UA40567C2 (uk) 2001-08-15
CN1039012C (zh) 1998-07-08
GR3029602T3 (en) 1999-06-30
JP3311431B2 (ja) 2002-08-05
BR9302809A (pt) 1994-03-15

Similar Documents

Publication Publication Date Title
EP0595133A3 (de) Prodrugs, ihre Herstellung und Verwendung als Arzneimittel
EP0225608A3 (de) Arzneimittel
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
AU570328B2 (en) Solid medicament formulations containing dihydropyridines
GR3024859T3 (en) 4,13-dioxabicyclo[8.2.1]tridecenon-derivatives, method and intermediates for their preparation, and medicaments containing the same
ZA934971B (en) Novel phospholipid derivatives
AU1630188A (en) Substituted compounds, processes for their preparation and their use as medicaments
EP0401262A4 (en) 24r-scymnol, and preparation and use thereof
GR3005838T3 (lv)
AU2823089A (en) 2,4- diaminoquinazoline derivatives
AU637400B2 (en) Substituted vinylcephalosporins, processes for their preparation and their use as medicaments
IL100940A0 (en) 17-beta-oestradiol derivatives,processes for their preparation and medicaments containing them